retatrutide wat is dat Retatrutide: a new approach to weight loss Retatrutide - 10 mg

Currently in Phase 2 and Phase 3 clinical trials, retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from existing licensed weight-loss medicines such as semaglutide and tirzepatide

This actually makes your transition slightly easier in some ways and slightly harder in others

For those looking to procure these advanced research tools, our catalog includes Tirzepatide, Semaglutide, and the emerging Retatrutide, all backed by our commitment to scientific excellence

The same volume at MOTS-c 10 mg/mL is 2 mg of MOTS-c

What if I gained it back

Repurposing of long-acting incretin-based therapies, including the GLP-1 receptor agonist semaglutide, the dual GLP-1/gastric inhibitory polypeptide (GIP) receptor agonist tirzepatide, and the triple GLP-1/GIP/glucagon agonist retatrutide, may offer a promising strategy treating AUD